Last updated on 12 Feb 2024
Owner Info
Allogene Therapeutics, Inc.
210 E. Grand Avenue
South San Francisco CA 94080, UNITED STATES OF AMERICA
Serial Number
2109464 filed on 6 Jul 2020
Correspondent
Jason S. Howell Perkins Coie LLP
1201 Third Avenue, Suite 4900,
Seattle WA 98101,
UNITED STATES OF AMERICA
2109464
6 Jul 2020
NA
WORD
8 Jan 2020
US
Status Date | Action Taken |
---|---|
12th Feb 2024 | Status change to Voided |
30th Dec 2020 | International Registration in Australia Protected correspondence sent |
29th Dec 2020 | IP Right Registration Published |
29th Dec 2020 | Status change to Registered/Protected |
21st Oct 2020 | Application Accepted correspondence sent |
20th Oct 2020 | IP Right has been Examined |
20th Oct 2020 | IP Right Acceptance Published |
20th Oct 2020 | Status change to Accepted |
6th Aug 2020 | Awaiting examination |
6th Aug 2020 | Examination expedited |